Shamburg News · 8-K filed Nov 12, 2026, 4:11 PM EST
Alumis Reports Third Quarter 2026 Financial Results and Business Updates
ALMS · ALUMIS INC.
- Earnings
- Other event
- Materiality: high
Alumis Inc. reported financial results for the quarter ended September 30, 2026, in a press release furnished under Item 2.02. Total revenue was $1.9 million, research and development expenses were $80.8 million, and net loss was $94.9 million, compared with a net loss of $110.8 million a year earlier. The company reported cash, cash equivalents and marketable securities of $431.3 million and said the LUMUS Phase 2b SLE trial of envudeucitinib did not meet its primary and secondary endpoints in the overall population.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001847367-26-000022.
Written from the filing by Shamburg Markets. Figures are as reported by the company.